13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • AR Operable GOJ

    Acronym: 

    AR Operable GOJ

    ACTRN/NCT /ethics: 

    Scientific title: 

    Summary of trial and patient characteristics

    Cancer Type Stomach & Oesophageal
    Trial Type Treatment
    Phase Phase II Tumour Stream Oesophageal Cancer
    Age Range 18 years and older Cancer Stage Clinical Trials - Cancer Stage
    Sex Both Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type Stomach & Oesophageal
    Trial Type Treatment
    Phase Phase II
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream Oesophageal Cancer
    Cancer Stage Clinical Trials - Cancer Stage
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    AR is a single-arm, multi-centre, open-label, phase-II clinical trial with safety run in neo-adjuvant chemo-radiotherapy plus immunotherapy with avelumab (carboplatin paclitaxel-RT-Avelumab) in operable oesophageal/OG) adenocarcinoma

    Lay Summary

    Sponsor / Cooperative group

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Flinders Medical Centre Alex Scott-Hoy alex.scott-hoy@sa.gov.au 08 8204 4830 Amitesh Roy Not Yet Recruiting